• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals


15.895 EUR 0.613 4.01%

As of 02:08:55 ET on 07/11/2014.

Snapshot for Cambrex Corp (XBX)

Open: 15.895 Day's Range: 15.895 - 15.895 Volume: 0
Previous Close: 15.282 52wk Range: 9.422 - 16.080 1-Yr Rtn: +38.72%

Stock Chart for XBX

No chart data available.
  • XBX:GR 15.895
  • 1M
  • 1Y
Interactive XBX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for XBX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 21.4811
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 1.0070
Est. PEG Ratio 1.4815
Market Cap (M EUR) 486.74
Shares Outstanding (M) 30.62
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 14.0000
Dividend Ex-Date 05/04/2007
5 Year Dividend Growth -
Next Earnings Announcement 08/01/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for XBX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for XBX

Cambrex Corp. supplies products, services, and technologies for the Life Sciences and fine chemicals industry. The Company builds platforms for use in manufacturing small molecule Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates including drug delivery. Cambrex's services include process & analytical development, scale-up in addition to generic APIs.

Steven M Klosk "Steve"President/CEOGregory P SargenExec VP/CFO
Shawn P CavanaghExec VP/COOWilliam M HaskelSenior VP/Secretary/Gen Cnsl
More Company Profile & Key Executives for XBX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil